- NASP Supports the SAFE TO WORK ACT Jul 30, 2020 WASHINGTON DC, (July 30, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
- Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees Jul 29, 2020 WASHINGTON, DC (July 29, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
- NASP Submits Comments to CMS Jul 23, 2020 WASHINGTON, DC (July 23, 2020) – The National Association of Specialty Pharmacy (NASP) recently submitted comments... read more
- NASP Member EVERSANA’s Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments Jul 23, 2020 EVERSANA, the leading provider of global commercial services to the life sciences industry, today announced a partnership with ICER to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments. read more
- NASP submits comments to CMS on CMS-284-P Jul 20, 2020 NASP submitted recommendations on sections of the rule to specifically address the needs of specialty patients and the pharmacies that serve their needs. read more
- NASP Supports the SAFE TO WORK Act Jun 29, 2020 NASP submitted a letter to leaders in Congress in support of the SAFE TO WORK Act. read more
- Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees Jun 29, 2020 NASP submitted a letter to HHS by NASP and the country's leading pharmacy groups stating that any action on a prescription drug rebate rule must address skyrocketing fees extracted by some pharmacy benefit managers on behalf of plan sponsors in Medicare Part D. read more
- NASP announces the 2020 Annual Meeting & Expo VIRTUAL EXPERIENCE! Jun 12, 2020 Utilizing innovation and cutting-edge technology, the NASP Annual Meeting Virtual Experience allows you to learn, share, foster partnerships, and earn CPE credits from the safety and comfort of your home or office. read more
- NASP submits comments to CMS on CMS-1744-IFC Jun 01, 2020 WASHINGTON, DC (June 1, 2020) – Please click here to read NASP’s comments submitted Monday, June... read more
- Patient Survey White Paper for 2018/2019 Patient Satisfaction Survey Program May 12, 2020 The National Association of Specialty Pharmacy (NASP) in partnership with the SullivanLuallin Group (SLG) is pleased... read more